In Silico Characterization of Pathogenic <i>ESR2</i> Coding and UTR Variants as Oncogenic Potential Biomarkers in Hormone-Dependent Cancers.

Progression-free survival (PFS) was also significant ( p = 6.730 × 10 −3 ; q = 0.0143), disease-specific survival (DSS) was nominally significant but borderline after FDR correction ( p = 0.0399; q = 0.0532), and disease-free survival (DFS) was not significant ( p = 0.0903; q = 0.0903) ( Figure 4 , Table S3 ).

also in 2,106 other papers